2004, Número S2
<< Anterior
Rev Mex Anest 2004; 27 (S2)
Parámetros de Práctica Mexicanos para el Diagnóstico y Manejo de los Estados de Choque
Tamariz-Cruz O, Moyao-García D, Carrillo-Esper R, Zaragoza-Delgadillo JC, Rivera-Flores J, Gutiérrez-Sougarret B., Castorena G, Martínez-Zubieta R, González Chon O, Gutiérrez R, Medina M, Rodríguez L, Vázquez I, Sotelo-Montaño MA, Serrano X, Baranda F, López MC
Idioma: Español
Referencias bibliográficas: 447
Paginas: 204-228
Archivo PDF: 474.20 Kb.
RESUMEN
Se desglosan y presentan los Parámetros de Práctica Mexicanos para el Diagnóstico y Manejo de los Estados de Choque (PPC), analizados y modificados de su primera versión, por la Fuerza de Trabajo Intercolegiada para la elaboración de los Parámetros de Práctica Mexicanos para el Diagnóstico y Manejo de los Estados de Choque. En este reporte describimos el producto del consenso de los expertos, en forma de lineamientos para el manejo de los diferentes estados de choque, los cuales fueron basados en los resultados del análisis epidemiológico obtenido de la encuesta nacional realizada por el Colegio Mexicano de Anestesiología. De esta forma los lineamientos presentados se adaptan a las condiciones reales de infraestructura, de muchos centros de atención hospitalaria dentro de la República Mexicana. Se incluyen algunas recomendaciones para la atención prehospitalaria del paciente en estado de choque, que incluyen características de identificación, transporte y estabilización del enfermo portador de este padecimiento.
REFERENCIAS (EN ESTE ARTÍCULO)
Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque del Colegio Mexicano de Anestesiología. Desarrollo Metodológico de la Primera Reunión del Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque. Parte I. Tamariz-Cruz O. (coordinador) Rev Mex Anest 2002;27(2):204-14.
Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque del Colegio Mexicano de Anestesiología. Desarrollo Metodológico de la Primera Reunión del Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque. Parte II. Tamariz-Cruz O. (coordinador) Rev Mex Anest 2002;28(3):34-45.
American College of Critical Care Medicine of the Society of Critical Care Medicine. Clinical practice parameters for hemodynamic support of sepsis in Adult Patients. Crit Care Med 1999;27:639-660.
Carcillo JA, Fields A. Task Force Committee Members. Clinical Parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002;30LÑ:1365-1376.
Werner M. Can Medical Decisions be standardized? Should they be? Clin Chem 1993;39(7):1361-8.
Coates JF. In defense of Delphi: A Review of Delphi assessment expert opinion, forecasting and group process by H. Sackman. Technological Forecasting and Social Change 1975;7:193-4.
Eddy DM. Practice Policies. What are they? JAMA 1990;263:877-80.
King JY. Practice guidelines and medical malpractice litigation. Med Law 1997;16(1):29-39.
Kapp MB. The legal status of clinical practice parameters: an annotated bibliography. Am J Med Qual 1993;8(1):24-7.
Kelly JT, Kellie SE. Appropriateness of medical care. Findings, strategies. Arch Pathol Lab Med 1990;114(11):1119-2.
Kelly JT, Swartwout JE. Development of practice parameters by physician organizations. QRB Qual Rev Bull 1990;16(2):54-7.
Ketzler J, Habibi S, Coursin DB. Development of clinical Guidelines in Critical Care Medicine. Anesth Clin of North Am 1997;4:873-84.
Coalition for Critical Care Excellence: Bone RC (Chairman) Standards of evidence for the safety and effectiveness of critical care monitoring devices and related interventions. Crit Care Med 1995;23:1756-1763.
Evidence - Based Medicine Working Group: Evidence - based medicine: A new approach to teaching the practice of medicine. JAMA 1992;268:2420-2425.
(Escala SAS) Riker RR, Fraser G, Cox PM. Continuous infusion haloperidol controls agitation in critically ill Patients. Crit Care Med 1994;22:433-440.
Ramsay M, Savege T, Simpson BRJ, et al. Controlled sedation with alphaxolone/alphadolone. BMJ 1974;2:656-9.
Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction. Ann Intern Med 1990;113:227-242.
American College of Physicians/SCCM Consensus Conference Definitions for Sepsis and Organ Failure. Crit Care Med 1992;20:864-875.
Rangel-Fraustro S, Pittet D, Costigan M, Hwang T, Davis C, Wenzel RP. The Natural History of SIRS. A Prospective Study. JAMA 1995;273:117-123.
Hollenberg SM, Parrillo JE. Shock. In: Harrison’s Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, et al (Eds.) New York, McGraw-Hill, 1997.pp. 214-222.
Rackow EC, Astiz ME. Mechanisms and management of septic shock. Crit Care Clin 1993;9:219-237.
Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100:483-490.
Astiz M, Rackow EC, Weil MH, et al. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock 1988;26:311-320.
Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992;267:1503-1510.
Hayes MA, Timmins AC, Yau EH, et al. Oxygen transport patterns in patients with sepsis syndrome or septic shock: Influence of treatment and relationship to outcome. Crit Care Med 1997;25:926-936.
Steffes CP, Dahn MS, Lange MP. Oxygen Transport-dependent splanchnic metabolism in the sepsis syndrome. Arch Surg 1994;129:46-52.
26a.Tamariz-Cruz O. Liver Oxygenation in Cirrhotic Patients. Surgery 1998;124:343-45.
Boekstegers P, Weidenhofer S, Pilz G, et al. Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 1991;5:317-323.
Bredle D, Samsel R, Schumacker P. Critical O2 delivery to skeletal muscle at high and low P O2 in endotoxemic dogs. J Appl Physiol 1989;66:2553-2558.
Rackow E, Astriz ME, Weil MH. Increases in oxygen extraction during rapidly fatal septic shock in rats. J Lab Clin Med 1987;109:660-664.
Gore DC, Jahoor F, Hibbert JM, et al. Lactic acidosis during sepsis in related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996;224:97-102.
Friedman G, Berlot G, Kahn RJ. Combined measurements of blood lactate levels and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995;23:1184-1193.
Vincent JL, Dufaye P, Berre J. Serial lactate determinations during circulatory shock. Crit Care Med 1983;11:449-451.
Bakker J, Coffemils M, Leon M, et al. Blood lactates are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1992;99:956-962.
Nelson D, Beyer C, Samsel R, et al. Pathologic supply dependence of systemic and intestinal O2 uptake during bacteremia in the dog. J Appl Physiol 1987;63:1487-1489.
De Backer D, Creteur J, Noordally O, et al. Does hepato-splanchnic V O2 /D O2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998;157:1219-1225.
Creteur J, De Backer D, Vincent JL. Monitoring gastric mucosal carbon dioxide pressure using gas tonometry: in vitro and in vivo validation studies. Anesthesiology 1997;87:504-510.
Russell JA. Gastric tonometry: Does it work? Intensive Care Med 1997;23:3-6.
Marik PE. Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993;104:225-229.
Maynard N, Bihari D, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993;270:1203-1210.
Gutierrez G, Palizas F, Doglio G, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992;339:195-199.
Doglio GR, Pusajo JF, Egurrola MA, et al. Gastric mucosal pH as a prognostic index of mortality in critical ill patients. Crit Care Med 1991;13:1037-1040.
Packman MJ, Rackow EC. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983;11:165-169.
Rackow EC, Falk JL, Fein IA. Fluid resuscitation in shock: A comparison of cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovolemic shock. Crit Care Med 1983;11:839-850.
Conrad S, Dietch K, Hebert C. Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 1990;31:419-429.
Mink R, Pollack M. Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med 1990;18:1087-1091.
Steffes C, Bender J, Levinson M. Blood transfusion and oxygen consumption in surgical sepsis. Crit Care Med 1991;19:512-517.
Marik P, Sibbald W. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993;269:3024-3029.
Tuchschmidt J, Friend J, Astric M, et al. Elevation of cardiac output and oxygen delivery improves outcome in sepsis shock. Chest 1992;102:216-220.
Yu M, Levy MM, Smith P, et al. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study. Crit Care Med 1993;21:830-838.
Hayes MA, Timmins AC, Yau EHS, et al. Elevations of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994;330:1717-1722.
Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995;333:1025-1032.
Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993;270:2699-2707.
Heyland DK, Cook DJ, King D, et al. Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Crit Care Med 1996;24:517-524.
Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997;23:282-287.
Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994;272:1354-1357.
Schreuder WO, Schneider AJ, Groeneveld ABJ, et al. Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Chest 1989;95:1282-1288.
Carroll G, Snyder J. Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 1982;243:R131-R141.
Rackow EC, Kaufman BS, Falk JL, et al. Hemodynamic response to fluid repletion in patient with septic shock: Evidence for early depression of cardiac performance. Circ Shock 1987;22:11-22.
Greenfield LJ, Jackson RH, Elkins RC. Cardiopulmonary effects of volume loading of primates in endotoxin shock. Surgery 1974;76:560-570.
Haupt MT, Gilbert EM, Carlson RW. Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Rev Respir Dis 1985;131:912-916.
Nelson A, Fleisher L, Roenbaum S. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860-866.
Morisaki H, Sibbald W, Martin C, et al. Hyperdynamic sepsis depresses the circulatory compensation of normovolemic anemia in conscious rats. J Appl Physiol 1996;82:656-664.
Silverman H, Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red cell transfusion. Chest 1992;102:184-189.
Hebert P, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417.
Lamke LO, Liljedahl SO. Plasma volume changes after infusion of various plasma expanders. Resuscitation 1996;5:85-92.
Boldt J, Muller M, Heesen M, et al. Influence of different volume therapies and pentoxifylline infusion on circulatory soluble adhesion molecules in critically ill patients. Crit Care Med 1996;24:358-391.
Morisaki H, Bloos F, Keys J, et al. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic. J Appl Physiol 1994;77:1507-1518.
Falk JL, Rackow EC, Astriz ML, et al. Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol 1988;28:412-415.
Schmand J, Ayala A, Morrison M, et al. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: Restoration of macrophage integrity and prevention of increased IL-6 levels. Crit Care Med 1995;23:806-814.
Cuyton AC, Lindsey AW. Effects of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959;7:649-657.
Kramer GC, Harms BA, Bodai BI, et al. Effects of hypoproteinemia and increased vascular pressure on lung fluid balance in sheep. J Appl Physiol 1983;55:1514-1522.
Rackow EC, Fein AI, Siegel J. The relationships of colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest 1982;82:433-437.
Sise MJ, Shackford SR, Peters RM, et al. Serum oncotic-hydrostatic pressure differences in critically ill patients. Anesth Analg 1982;61:496-498.
Virgilio RW, Rice CL, Smith DE, et al. Crystalloid vs colloid resuscitation. Which one is better? A randomized clinical study. Surgery 1979;85:129-139.
Rackow EC, Astriz ME, Janz T, et al. Absence of pulmonary edema during peritonitis and shock in rats. J Lab Clin Med 1989;112:264-269.
Metildi LA, Shackford SR, Virgilio RW, et al. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 1984;158:207-212.
Baum TD, Wang H, Rothschild HR, et al. Mesenteric oxygen metabolism, ileal mucosal hydrogen ion concentration and tissue edema after crystalloid or colloid resuscitation in porcine endotoxic shock: Comparison of Ringer’s lactate and 6% hetastarch. Circ Shock 1990;30:385-397.
Rackow EC, Astriz ME, Schumer W, et al. Lung and muscle water after crystalloid and colloid infusion in septic rats: Effect on oxygen delivery and metabolism. J Lab Clin Med 1989;113:184-189.
O’Brien R, Murdoch J, Kuehm R, et al. The effect of albumin or crystalloid resuscitation on bacterial translocation and endotoxin absorption following experimental burn injury. J Surg Res 1992;52:161-166.
Tollosfrud S, Eligio GI, Prough DS, et al. The dynamics of vascular volume and fluid shifts of lactated Ringer’s solution and hypertonic saline-dextran solutions infused in normovolemic sheep. Anesth Analg 2002;93:823-831.
Barrow RE, Jeschke MG, Herdon DN. Early fluid resuscitation improves outcomes in severely burned children. Resuscitation 2002;45:91-96.
Traber DL. Fluid resuscitation after hypovolemia. Crit Care Med 2002;30:1922.
Blanloeil Y, Trossaert M, Rigal JC, Rozec B. Effects of plasma substitutes on hemostasis. Ann Fr Anesth Reanim 2002;21(8):648-67.
De Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001;29(6):1261-7.
De Hert SG, Vermeyen KM, Himpe DG, Adriaensen HF. Oxygen transport and myocardial function after the administration of albumin 5%, hydroxyethylstarch 6% and succinylated gelatine 4% to rabbits. Eur J Anaesthesiol Dec 2002;19:860-8.
Vasopresores, inotrópicos y apoyo hemodinámico
Rudis MI, Basha MA, Zarowitz BJ. Is it time to reposition vasopressors in sepsis? Crit Care Med 1996;24:525-537.
Bersten AD, Holt AW. Vasoactive drugs an the importance of renal perfusion pressure. New Horiz 1995;3:650-661.
Kirchheim HR, Ehmke H, Hackenthal E, et al. Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 1987;410:441-449.
Barry K, Mazze R, Schwarz F. Prevention of surgical oliguria and renal hemodynamic suppression by sustained Hydration. N Engl J Med 1967;270:1371-1377.
Bush HL Jr, Huse JB, Johnson WC, et al. Prevention of renal insufficiency after abdominal aortic aneurysm resection by optimal volume loading. Arch Surg 1981;116:1517-1524.
Kelleher SP, Robinette JB, Conger JD. Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol 1984;246:F379-F386.
Martin C, Saux P, Eon B, et al. Septic shock: A goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 1990;34:413-417.
Hoffman MJ, Greenfield LJ, Sugerman HJ, et al. Unsuspected right ventricular dysfunction in shock and sepsis. Arch Surg 1983;198:307-319.
Martin C, Perrin G, Saux P, et al. Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med 1994;20:444-447.
Vincent JL, Reuse C, Frank N, et al. Right ventricular dysfunction in sepsis shock: Assessment by measurements of right ventricular ejection fraction using the thermodilution technique. Acta Anaesthesiol Scand 1989;33:34-38.
Desjars P, Pinaud M, Tasseau F, et al. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987;15:134-137.
Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989;17:426-429.
Bollaert PE, Bauer P, Audibert G, et al. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990;98:949-953.
Fukuoka T, Nishimura M, Imanaka H, et al. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 1989;17:1104-1107.
Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: Effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989;17:179-180.
Lipman J, Roux A, Kraus P. Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 1991;19:61-65.
Martin C, Eon B, Saux P, et al. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990;18:282-285.
Meadows D, Edwards JD, Wilkins RG, et al. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988;16:663-667.
Redl-Wenzl EM, Armbruster C, Edelmann G, et al. The effects of norepinephrine on haemodynamics and renal function in severe septic shock states. Intensive Care Med 1993;19:151-154.
Gregory JS, Bonfiglio MF, Dasta JF, et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991;19:1395-1400.
Meier-Hellmann A, Bredle DL, Specht DL, et al. The effects of low-dose dopamine on splanchnic blood flow and oxygen utilization in patients with septic shock. Intensive Care Med 1997;23:31-37.
Hannemann L, Reinhart K, Grenzer O, et al. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995;23:1962-1970.
Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993;21:1296-1303.
Jardin F, Gurdjian F, Desfonds P, et al. Effects of dopamine on intrapulmonary shunt fraction and oxygen transport in severe sepsis with circulatory and respiratory failure. Crit Care Med 1979;7:273-277.
Jardin F, Eveleigh MC, Gurdjian F, et al. Venous admixture in human septic shock. Comparative effects of blood volume expansion, dopamine infusion and isoproterenol infusion in mismatching of ventilation and pulmonary blood flow in peritonitis. Circulation 1979;60:155-159.
Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993;103:1826-1831.
Regnier B, Safran D, Carlet J, et al. Comparative haemodynamic effects of dopamine and dobutamine in sepsis shock. Intensive Care Med 1979;5:115-120.
Samii K, Le Gall JR, Regnier B, et al. Haemodynamic effects of dopamine in septic shock with and without acute renal failure. Arch Surg 1978;113:1414-1416.
Regnier B, Rapin M, Gory G, et al. Hemodynamic effects of dopamine in septic shock. Intensive Care Med 1977;3:47-53.
Maynard ND, Bihari DJ, Dalton RN, et al. Increasing splanchnic blood flow in the critically ill. Chets 1995;108:1648-1654.
Neviere R, Mathieu D, Chagnon JL, et al. The contrasting effects of dopamine on mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996;154:1684-1688.
Wilson W, Lipman J, Scribante J, et al. Septic shock: Does adrenaline have a role as a first-line inotropic agent? Anaesth Intensive Care 1992;20:470-474.
Moran JL, O’Fathartaigh MS, Peisach AR, et al. Epinephrine as a inotropic agent in septic shock: A dose-profile analysis. Crit Care Med 1993;21:70-77.
Mackenzie SJ, Kapadia F, Nimmo GR, et al. Adrenaline in treatment of sepsis shock: Effects on haemodynamics and oxygen transport. Intensive Care Med 1991;17:36-39.
Le Tulzo Y, Seguin P, Gacouin A, et al. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary study. Intensive Care Med 1997;23:667-670.
Day NP, Phu NH, Bethell DP, et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996;348:219-223.
Levy B, Bollaert PE, Lucchelli JP, et al. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated shock. Crit Care Med 1997;25:1649-1654.
Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: Clinical and experimental approaches. Circ Shock 1986;19:141-155.
Martin C, Yaghi A, Sibbald W, et al. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 1993;148:164-172.
Nelson L, Snyder J. Technical problems in data acquisition. In: Oxygen Transport in the Critically III. Vol 15. Snyder JV, Pinsky MR (Eds). Chicago, Year Book Medical Publishing, 1987.pp. 205-234.
Eckstein J, Abboud F. Circulation effect of sympathomimetic amines. Am Heart J 1962;63:119-121.
Mills L, Moyer J, Handley C. Effects of various sympathomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol 1960;198:1279-1284.
Murakawa K, Kobayashi A. Effects of vasopressors on renal tissue gas tensions during hemorrhagic shock in dogs. Cirt Care Med 1988;16:789-792.
Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985;13:492-496.
Hoogenberg K, Smit AJ, Girbes ARJ: Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 1998;26:260-265.
Reinelt H, Radermacher P, Fischer G, et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997;86:818-824.
Data JF. Norepinephrine in septic shock. Renewed interest in an old drug. DICP Ann Pharmacother 1990;24:153-156.
Moyer J, Skelton J, Mills L. Norepinephrine: Effects in normal subjects; use in treatment of shock unresponsive to other measure. Am J Med 1953;15:330-343.
Yamazaki T, Shimada Y, Taenaka N, et al. Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med 1982;10:452-435.
Flancbaum L, Dick M, Dasta J, et al. A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997;51:461-465.
Angelos MG, Murray HN, Waite MD, Gorsline RT. Postischemic inotropic support of the dysfunctional heart. Crit Care Med 2002;30:410-416.
Hemodinamia, respuesta inflamatoria y cinética
de oxigenación global y regional
Parker M, Suffredini A, Natanson C, et al. Responses of left ventricular function in survivors and nonsurvivors of septic shock. J Crit Care 1989;4:19-25.
Raper R, Sibbald M, Driedger A, et al. Relative myocardial depression in normotensive septic. J Crit Care 1989;4:9-18.
Parker MM, McCarthy K, Ognibene FP, et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990;97:126-131.
Parker MM, Ognibene FP, Parrillo JE. Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shock. Crit Care Med 1994;22:1955-1959.
Ognibene FP, Parker MM, Natanson C, et al. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988;93:903-901.
Dhainaut JF, Huyghebaert MF, Monsallier JF, et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987;75:533-541.
Cunnion RE, Schaer GL, Parker MM, et al. The coronary circulation in human septic shock. Circulation 1986;73:637-644.
Gotloib L, Shostak A, Galdi P, et al. Loss of microvascular negative charges accompanied by interstitial edema in septic rats heart. Circ Shock 1992;36:45-56.
Liu MS, Wu LL. Heart sarcolemmal Ca2+ transport in endotoxin shock: II. Mechanism of impairment in ATP-dependent Ca2+ transport. Mol Cell Biochem 1992;112:135-142.
Bensard DD, Banerjee A, McIntyre RC Jr, et al. Endotoxin disrupts beta-adrenergic signal transduction in the heart. Arch Surg 1994;129:198-204; discussion 204-205.
Baum TD, Heard SO, Feldman HS, et al. Endotoxin-induced myocardial depression in rats: Effects of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist. J Surg Res 1990;48:629-634.
Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
Brady AJB, Poole-Wilson PA, Harding SE, et al. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-H1966.
Schulz R, Nava E, Moncada S. Introduction and potential biological relevance on o Ca2+ -independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992;105:575-580.
Gilbert EM, Haupt MT, Mandanas RY, et al. The effects of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis 1986;134:873-878.
Ronco JJ, Fenwick JC, Tweeddale MG, et al. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993;270:1724-1730.
Jain A, Shroff SG, Janicki JS, et al. Relation between mixed venous oxygen saturation and cardiac index. Nonlinearity and normalization for oxygen uptake and hemoglobin. Chest 1991;99:1403-1409.
Vaughn S, Puri VK. Cardiac output changes continuous mixed venous oxygen saturation measurement in the critically ill. Crit Care Med 1988;16:495-498.
Nasraway SA, Rackow EC, Astriz ME, et al. Inotropic response to digoxin and patients with severe sepsis, cardiac failure, and systemic hypoperfusion. Chest 1989;95:612-615.
de la Cal MA, Miravalles E, Pascual T, et al. Dose-related hemodynamic and renal effects of dopamine in septic shock. Crit Care Med 1984;12:22-25.
Jardin F, Sportiche M, Bazin M, et al. Dobutamine: A hemodynamic valuation in human septic shock. Crit Care Med 1981;9:329-332.
De Backer D, Berre J, Zhang H, et al. Relationship between oxygen uptake and oxygen delivery in septic patients: Effects of prostacyclin versus dobutamine. Crit Care Med 1993;21:1658-1664.
Vallet B, Chopin C, Curtis SE, et al. Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: A prospective, multicenter study. Crit Care Med 1993;21:1868-1875.
Gutierrez G, Clark C, Brown SD, et al. Effects of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 1994;150:324-329.
De Backer D, Moraine JJ, Berre J, et al. Effects of dobutamine on oxygen consumption in septic patients. Direct versus indirect determinations. Am J Respir Crit Care Med 1994;150:95-100.
Ronco JJ, Fenwick JC, Wiggs BR, et al. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis 1993;147:25-31.
Vincent JL, Roman A, Kahn RJ. Dobutamine administration in septic shock: Addition to a standard protocol. Crit Care Med 1990;18:689-693.
Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque del Colegio Mexicano de Anestesiología. Desarrollo Metodológico de la Primera Reunión del Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque. Parte I. Tamariz-Cruz O. (coordinador) Rev Mex Anest 2002;27(2):204-14.
Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque del Colegio Mexicano de Anestesiología. Desarrollo Metodológico de la Primera Reunión del Grupo de Consenso para el Diagnóstico y Manejo de los Estados de Choque. Parte II. Tamariz-Cruz O. (coordinador) Rev Mex Anest 2002;28(3):34-45.
American College of Critical Care Medicine of the Society of Critical Care Medicine. Clinical practice parameters for hemodynamic support of sepsis in Adult Patients. Crit Care Med 1999;27:639-660.
Carcillo JA, Fields A. Task Force Committee Members. Clinical Parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002;30LÑ:1365-1376.
Werner M. Can Medical Decisions be standardized? Should they be? Clin Chem 1993;39(7):1361-8.
Coates JF. In defense of Delphi: A Review of Delphi assessment expert opinion, forecasting and group process by H. Sackman. Technological Forecasting and Social Change 1975;7:193-4.
Eddy DM. Practice Policies. What are they? JAMA 1990;263:877-80.
King JY. Practice guidelines and medical malpractice litigation. Med Law 1997;16(1):29-39.
Kapp MB. The legal status of clinical practice parameters: an annotated bibliography. Am J Med Qual 1993;8(1):24-7.
Kelly JT, Kellie SE. Appropriateness of medical care. Findings, strategies. Arch Pathol Lab Med 1990;114(11):1119-2.
Kelly JT, Swartwout JE. Development of practice parameters by physician organizations. QRB Qual Rev Bull 1990;16(2):54-7.
Ketzler J, Habibi S, Coursin DB. Development of clinical Guidelines in Critical Care Medicine. Anesth Clin of North Am 1997;4:873-84.
Coalition for Critical Care Excellence: Bone RC (Chairman) Standards of evidence for the safety and effectiveness of critical care monitoring devices and related interventions. Crit Care Med 1995;23:1756-1763.
Evidence - Based Medicine Working Group: Evidence - based medicine: A new approach to teaching the practice of medicine. JAMA 1992;268:2420-2425.
(Escala SAS) Riker RR, Fraser G, Cox PM. Continuous infusion haloperidol controls agitation in critically ill Patients. Crit Care Med 1994;22:433-440.
Ramsay M, Savege T, Simpson BRJ, et al. Controlled sedation with alphaxolone/alphadolone. BMJ 1974;2:656-9.
Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction. Ann Intern Med 1990;113:227-242.
American College of Physicians/SCCM Consensus Conference Definitions for Sepsis and Organ Failure. Crit Care Med 1992;20:864-875.
Rangel-Fraustro S, Pittet D, Costigan M, Hwang T, Davis C, Wenzel RP. The Natural History of SIRS. A Prospective Study. JAMA 1995;273:117-123.
Hollenberg SM, Parrillo JE. Shock. In: Harrison’s Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, et al (Eds.) New York, McGraw-Hill, 1997.pp. 214-222.
Rackow EC, Astiz ME. Mechanisms and management of septic shock. Crit Care Clin 1993;9:219-237.
Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100:483-490.
Astiz M, Rackow EC, Weil MH, et al. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock 1988;26:311-320.
Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992;267:1503-1510.
Hayes MA, Timmins AC, Yau EH, et al. Oxygen transport patterns in patients with sepsis syndrome or septic shock: Influence of treatment and relationship to outcome. Crit Care Med 1997;25:926-936.
Steffes CP, Dahn MS, Lange MP. Oxygen Transport-dependent splanchnic metabolism in the sepsis syndrome. Arch Surg 1994;129:46-52.
26a. Tamariz-Cruz O. Liver Oxygenation in Cirrhotic Patients. Surgery 1998;124:343-45.
Boekstegers P, Weidenhofer S, Pilz G, et al. Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 1991;5:317-323.
Bredle D, Samsel R, Schumacker P. Critical O2 delivery to skeletal muscle at high and low P O2 in endotoxemic dogs. J Appl Physiol 1989;66:2553-2558.
Rackow E, Astriz ME, Weil MH. Increases in oxygen extraction during rapidly fatal septic shock in rats. J Lab Clin Med 1987;109:660-664.
Gore DC, Jahoor F, Hibbert JM, et al. Lactic acidosis during sepsis in related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996;224:97-102.
Friedman G, Berlot G, Kahn RJ. Combined measurements of blood lactate levels and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995;23:1184-1193.
Vincent JL, Dufaye P, Berre J. Serial lactate determinations during circulatory shock. Crit Care Med 1983;11:449-451.
Bakker J, Coffemils M, Leon M, et al. Blood lactates are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1992;99:956-962.
Nelson D, Beyer C, Samsel R, et al. Pathologic supply dependence of systemic and intestinal O2 uptake during bacteremia in the dog. J Appl Physiol 1987;63:1487-1489.
De Backer D, Creteur J, Noordally O, et al. Does hepato-splanchnic V O2 /D O2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998;157:1219-1225.
Creteur J, De Backer D, Vincent JL. Monitoring gastric mucosal carbon dioxide pressure using gas tonometry: in vitro and in vivo validation studies. Anesthesiology 1997;87:504-510.
Russell JA. Gastric tonometry: Does it work? Intensive Care Med 1997;23:3-6.
Marik PE. Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993;104:225-229.
Maynard N, Bihari D, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993;270:1203-1210.
Gutierrez G, Palizas F, Doglio G, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992;339:195-199.
Doglio GR, Pusajo JF, Egurrola MA, et al. Gastric mucosal pH as a prognostic index of mortality in critical ill patients. Crit Care Med 1991;13:1037-1040.
Packman MJ, Rackow EC. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983;11:165-169.
Rackow EC, Falk JL, Fein IA. Fluid resuscitation in shock: A comparison of cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovolemic shock. Crit Care Med 1983;11:839-850.
Conrad S, Dietch K, Hebert C. Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 1990;31:419-429.
Mink R, Pollack M. Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med 1990;18:1087-1091.
Steffes C, Bender J, Levinson M. Blood transfusion and oxygen consumption in surgical sepsis. Crit Care Med 1991;19:512-517.
Marik P, Sibbald W. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993;269:3024-3029.
Tuchschmidt J, Friend J, Astric M, et al. Elevation of cardiac output and oxygen delivery improves outcome in sepsis shock. Chest 1992;102:216-220.
Yu M, Levy MM, Smith P, et al. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study. Crit Care Med 1993;21:830-838.
Hayes MA, Timmins AC, Yau EHS, et al. Elevations of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994;330:1717-1722.
Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995;333:1025-1032.
Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993;270:2699-2707.
Heyland DK, Cook DJ, King D, et al. Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Crit Care Med 1996;24:517-524.
Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997;23:282-287.
Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994;272:1354-1357.
Schreuder WO, Schneider AJ, Groeneveld ABJ, et al. Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Chest 1989;95:1282-1288.
Carroll G, Snyder J. Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 1982;243:R131-R141.
Rackow EC, Kaufman BS, Falk JL, et al. Hemodynamic response to fluid repletion in patient with septic shock: Evidence for early depression of cardiac performance. Circ Shock 1987;22:11-22.
Greenfield LJ, Jackson RH, Elkins RC. Cardiopulmonary effects of volume loading of primates in endotoxin shock. Surgery 1974;76:560-570.
Haupt MT, Gilbert EM, Carlson RW. Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Rev Respir Dis 1985;131:912-916.
Nelson A, Fleisher L, Roenbaum S. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860-866.
Morisaki H, Sibbald W, Martin C, et al. Hyperdynamic sepsis depresses the circulatory compensation of normovolemic anemia in conscious rats. J Appl Physiol 1996;82:656-664.
Silverman H, Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red cell transfusion. Chest 1992;102:184-189.
Hebert P, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417.
Lamke LO, Liljedahl SO. Plasma volume changes after infusion of various plasma expanders. Resuscitation 1996;5:85-92.
Boldt J, Muller M, Heesen M, et al. Influence of different volume therapies and pentoxifylline infusion on circulatory soluble adhesion molecules in critically ill patients. Crit Care Med 1996;24:358-391.
Morisaki H, Bloos F, Keys J, et al. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic. J Appl Physiol 1994;77:1507-1518.
Falk JL, Rackow EC, Astriz ML, et al. Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol 1988;28:412-415.
Schmand J, Ayala A, Morrison M, et al. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: Restoration of macrophage integrity and prevention of increased IL-6 levels. Crit Care Med 1995;23:806-814.
Cuyton AC, Lindsey AW. Effects of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959;7:649-657.
Kramer GC, Harms BA, Bodai BI, et al. Effects of hypoproteinemia and increased vascular pressure on lung fluid balance in sheep. J Appl Physiol 1983;55:1514-1522.
Rackow EC, Fein AI, Siegel J. The relationships of colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest 1982;82:433-437.
Sise MJ, Shackford SR, Peters RM, et al. Serum oncotic-hydrostatic pressure differences in critically ill patients. Anesth Analg 1982;61:496-498.
Virgilio RW, Rice CL, Smith DE, et al. Crystalloid vs colloid resuscitation. Which one is better? A randomized clinical study. Surgery 1979;85:129-139.
Rackow EC, Astriz ME, Janz T, et al. Absence of pulmonary edema during peritonitis and shock in rats. J Lab Clin Med 1989;112:264-269.
Metildi LA, Shackford SR, Virgilio RW, et al. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 1984;158:207-212.
Baum TD, Wang H, Rothschild HR, et al. Mesenteric oxygen metabolism, ileal mucosal hydrogen ion concentration and tissue edema after crystalloid or colloid resuscitation in porcine endotoxic shock: Comparison of Ringer’s lactate and 6% hetastarch. Circ Shock 1990;30:385-397.
Rackow EC, Astriz ME, Schumer W, et al. Lung and muscle water after crystalloid and colloid infusion in septic rats: Effect on oxygen delivery and metabolism. J Lab Clin Med 1989;113:184-189.
O’Brien R, Murdoch J, Kuehm R, et al. The effect of albumin or crystalloid resuscitation on bacterial translocation and endotoxin absorption following experimental burn injury. J Surg Res 1992;52:161-166.
Tollosfrud S, Eligio GI, Prough DS, et al. The dynamics of vascular volume and fluid shifts of lactated Ringer’s solution and hypertonic saline-dextran solutions infused in normovolemic sheep. Anesth Analg 2002;93:823-831.
Barrow RE, Jeschke MG, Herdon DN. Early fluid resuscitation improves outcomes in severely burned children. Resuscitation 2002;45:91-96.
Traber DL. Fluid resuscitation after hypovolemia. Crit Care Med 2002;30:1922.
Blanloeil Y, Trossaert M, Rigal JC, Rozec B. Effects of plasma substitutes on hemostasis. Ann Fr Anesth Reanim 2002;21(8):648-67.
De Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001;29(6):1261-7.
De Hert SG, Vermeyen KM, Himpe DG, Adriaensen HF. Oxygen transport and myocardial function after the administration of albumin 5%, hydroxyethylstarch 6% and succinylated gelatine 4% to rabbits. Eur J Anaesthesiol Dec 2002;19:860-8.
Rudis MI, Basha MA, Zarowitz BJ. Is it time to reposition vasopressors in sepsis? Crit Care Med 1996;24:525-537.
Bersten AD, Holt AW. Vasoactive drugs an the importance of renal perfusion pressure. New Horiz 1995;3:650-661.
Kirchheim HR, Ehmke H, Hackenthal E, et al. Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 1987;410:441-449.
Barry K, Mazze R, Schwarz F. Prevention of surgical oliguria and renal hemodynamic suppression by sustained Hydration. N Engl J Med 1967;270:1371-1377.
Bush HL Jr, Huse JB, Johnson WC, et al. Prevention of renal insufficiency after abdominal aortic aneurysm resection by optimal volume loading. Arch Surg 1981;116:1517-1524.
Kelleher SP, Robinette JB, Conger JD. Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol 1984;246:F379-F386.
Martin C, Saux P, Eon B, et al. Septic shock: A goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 1990;34:413-417.
Hoffman MJ, Greenfield LJ, Sugerman HJ, et al. Unsuspected right ventricular dysfunction in shock and sepsis. Arch Surg 1983;198:307-319.
Martin C, Perrin G, Saux P, et al. Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med 1994;20:444-447.
Vincent JL, Reuse C, Frank N, et al. Right ventricular dysfunction in sepsis shock: Assessment by measurements of right ventricular ejection fraction using the thermodilution technique. Acta Anaesthesiol Scand 1989;33:34-38.
Desjars P, Pinaud M, Tasseau F, et al. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987;15:134-137.
Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989;17:426-429.
Bollaert PE, Bauer P, Audibert G, et al. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990;98:949-953.
Fukuoka T, Nishimura M, Imanaka H, et al. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 1989;17:1104-1107.
Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: Effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989;17:179-180.
Lipman J, Roux A, Kraus P. Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 1991;19:61-65.
Martin C, Eon B, Saux P, et al. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990;18:282-285.
Meadows D, Edwards JD, Wilkins RG, et al. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988;16:663-667.
Redl-Wenzl EM, Armbruster C, Edelmann G, et al. The effects of norepinephrine on haemodynamics and renal function in severe septic shock states. Intensive Care Med 1993;19:151-154.
Gregory JS, Bonfiglio MF, Dasta JF, et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991;19:1395-1400.
Meier-Hellmann A, Bredle DL, Specht DL, et al. The effects of low-dose dopamine on splanchnic blood flow and oxygen utilization in patients with septic shock. Intensive Care Med 1997;23:31-37.
Hannemann L, Reinhart K, Grenzer O, et al. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995;23:1962-1970.
Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993;21:1296-1303.
Jardin F, Gurdjian F, Desfonds P, et al. Effects of dopamine on intrapulmonary shunt fraction and oxygen transport in severe sepsis with circulatory and respiratory failure. Crit Care Med 1979;7:273-277.
Jardin F, Eveleigh MC, Gurdjian F, et al. Venous admixture in human septic shock. Comparative effects of blood volume expansion, dopamine infusion and isoproterenol infusion in mismatching of ventilation and pulmonary blood flow in peritonitis. Circulation 1979;60:155-159.
Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993;103:1826-1831.
Regnier B, Safran D, Carlet J, et al. Comparative haemodynamic effects of dopamine and dobutamine in sepsis shock. Intensive Care Med 1979;5:115-120.
Samii K, Le Gall JR, Regnier B, et al. Haemodynamic effects of dopamine in septic shock with and without acute renal failure. Arch Surg 1978;113:1414-1416.
Regnier B, Rapin M, Gory G, et al. Hemodynamic effects of dopamine in septic shock. Intensive Care Med 1977;3:47-53.
Maynard ND, Bihari DJ, Dalton RN, et al. Increasing splanchnic blood flow in the critically ill. Chets 1995;108:1648-1654.
Neviere R, Mathieu D, Chagnon JL, et al. The contrasting effects of dopamine on mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996;154:1684-1688.
Wilson W, Lipman J, Scribante J, et al. Septic shock: Does adrenaline have a role as a first-line inotropic agent? Anaesth Intensive Care 1992;20:470-474.
Moran JL, O’Fathartaigh MS, Peisach AR, et al. Epinephrine as a inotropic agent in septic shock: A dose-profile analysis. Crit Care Med 1993;21:70-77.
Mackenzie SJ, Kapadia F, Nimmo GR, et al. Adrenaline in treatment of sepsis shock: Effects on haemodynamics and oxygen transport. Intensive Care Med 1991;17:36-39.
Le Tulzo Y, Seguin P, Gacouin A, et al. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary study. Intensive Care Med 1997;23:667-670.
Day NP, Phu NH, Bethell DP, et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996;348:219-223.
Levy B, Bollaert PE, Lucchelli JP, et al. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated shock. Crit Care Med 1997;25:1649-1654.
Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: Clinical and experimental approaches. Circ Shock 1986;19:141-155.
Martin C, Yaghi A, Sibbald W, et al. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 1993;148:164-172.
Nelson L, Snyder J. Technical problems in data acquisition. In: Oxygen Transport in the Critically III. Vol 15. Snyder JV, Pinsky MR (Eds). Chicago, Year Book Medical Publishing, 1987.pp. 205-234.
Eckstein J, Abboud F. Circulation effect of sympathomimetic amines. Am Heart J 1962;63:119-121.
Mills L, Moyer J, Handley C. Effects of various sympathomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol 1960;198:1279-1284.
Murakawa K, Kobayashi A. Effects of vasopressors on renal tissue gas tensions during hemorrhagic shock in dogs. Cirt Care Med 1988;16:789-792.
Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985;13:492-496.
Hoogenberg K, Smit AJ, Girbes ARJ: Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 1998;26:260-265.
Reinelt H, Radermacher P, Fischer G, et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997;86:818-824.
Data JF. Norepinephrine in septic shock. Renewed interest in an old drug. DICP Ann Pharmacother 1990;24:153-156.
Moyer J, Skelton J, Mills L. Norepinephrine: Effects in normal subjects; use in treatment of shock unresponsive to other measure. Am J Med 1953;15:330-343.
Yamazaki T, Shimada Y, Taenaka N, et al. Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med 1982;10:452-435.
Flancbaum L, Dick M, Dasta J, et al. A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997;51:461-465.
Angelos MG, Murray HN, Waite MD, Gorsline RT. Postischemic inotropic support of the dysfunctional heart. Crit Care Med 2002;30:410-416.
Parker M, Suffredini A, Natanson C, et al. Responses of left ventricular function in survivors and nonsurvivors of septic shock. J Crit Care 1989;4:19-25.
Raper R, Sibbald M, Driedger A, et al. Relative myocardial depression in normotensive septic. J Crit Care 1989;4:9-18.
Parker MM, McCarthy K, Ognibene FP, et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990;97:126-131.
Parker MM, Ognibene FP, Parrillo JE. Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shock. Crit Care Med 1994;22:1955-1959.
Ognibene FP, Parker MM, Natanson C, et al. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988;93:903-901.
Dhainaut JF, Huyghebaert MF, Monsallier JF, et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987;75:533-541.
Cunnion RE, Schaer GL, Parker MM, et al. The coronary circulation in human septic shock. Circulation 1986;73:637-644.
Gotloib L, Shostak A, Galdi P, et al. Loss of microvascular negative charges accompanied by interstitial edema in septic rats heart. Circ Shock 1992;36:45-56.
Liu MS, Wu LL. Heart sarcolemmal Ca2+ transport in endotoxin shock: II. Mechanism of impairment in ATP-dependent Ca2+ transport. Mol Cell Biochem 1992;112:135-142.
Bensard DD, Banerjee A, McIntyre RC Jr, et al. Endotoxin disrupts beta-adrenergic signal transduction in the heart. Arch Surg 1994;129:198-204; discussion 204-205.
Baum TD, Heard SO, Feldman HS, et al. Endotoxin-induced myocardial depression in rats: Effects of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist. J Surg Res 1990;48:629-634.
Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
Brady AJB, Poole-Wilson PA, Harding SE, et al. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-H1966.
Schulz R, Nava E, Moncada S. Introduction and potential biological relevance on o Ca2+ -independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992;105:575-580.
Gilbert EM, Haupt MT, Mandanas RY, et al. The effects of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis 1986;134:873-878.
Ronco JJ, Fenwick JC, Tweeddale MG, et al. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993;270:1724-1730.
Jain A, Shroff SG, Janicki JS, et al. Relation between mixed venous oxygen saturation and cardiac index. Nonlinearity and normalization for oxygen uptake and hemoglobin. Chest 1991;99:1403-1409.
Vaughn S, Puri VK. Cardiac output changes continuous mixed venous oxygen saturation measurement in the critically ill. Crit Care Med 1988;16:495-498.
Nasraway SA, Rackow EC, Astriz ME, et al. Inotropic response to digoxin and patients with severe sepsis, cardiac failure, and systemic hypoperfusion. Chest 1989;95:612-615.
de la Cal MA, Miravalles E, Pascual T, et al. Dose-related hemodynamic and renal effects of dopamine in septic shock. Crit Care Med 1984;12:22-25.
Jardin F, Sportiche M, Bazin M, et al. Dobutamine: A hemodynamic valuation in human septic shock. Crit Care Med 1981;9:329-332.
De Backer D, Berre J, Zhang H, et al. Relationship between oxygen uptake and oxygen delivery in septic patients: Effects of prostacyclin versus dobutamine. Crit Care Med 1993;21:1658-1664.
Vallet B, Chopin C, Curtis SE, et al. Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: A prospective, multicenter study. Crit Care Med 1993;21:1868-1875.
Gutierrez G, Clark C, Brown SD, et al. Effects of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 1994;150:324-329.
De Backer D, Moraine JJ, Berre J, et al. Effects of dobutamine on oxygen consumption in septic patients. Direct versus indirect determinations. Am J Respir Crit Care Med 1994;150:95-100.
Ronco JJ, Fenwick JC, Wiggs BR, et al. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis 1993;147:25-31.
Vincent JL, Roman A, Kahn RJ. Dobutamine administration in septic shock: Addition to a standard protocol. Crit Care Med 1990;18:689-693.
Mira JP, Fabre JE, Baigorri F, et al. Lack of oxygen supply dependency in patients with severe sepsis. A study of oxygen delivery increased by military antishock trouser and dobutamine. Chest 1994;106:1524-1531.
Redl-Wenzl EM, Armbruster C, Edelmann G, et al. Noradrenaline in the “high output-low resistance” state of patients with abdominal sepsis. Anaesthesist 1990;39:525-529.
Tell B, Majerus TC, Flancbaum L. Dobutamine in elderly septic shock patients refractory to dopamine. Intensive Care Med 1987;13:14-18.
Barton P, Garcia J, Kouatli A, et al. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996;109:1302-1312.
Hannemann L, Reinhart K, Meier-Hellmann A, et al. Dopexamine hydrochloride in septic shock. Chest 1996;109:756-760.
Lund N, de Asla RJ, Cladis F, et al. Dopexamine hydrochloride in septic shock: Effects on oxygen delivery and oxygenation of gut, liver, and muscle. J Trauma 1995;38:767-775.
Cain SM, Curtis SE. Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Crit Care Med 1991; 19: 1552-1560.
Cain SM, Curtis SE. Systemic and regional oxygen uptake and lactate flux in endotoxic dogs resuscitated with dextran and dopexamine or dextran alone. Circ Shock 1992;38:173-181.
Palsson J, Ricksten SE, Houltz E, et al. Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats. Acta Anaesthesiol Scand 1997;41:392-398.
van Lambalgen AA, van Kraats AA, Mulder MF, et al. Organ blood flow and distribution of cardiac output in dopexamine-or dobutamine-treated endotoxemic rats. J Crit Care 1993;8:117-127.
Colardyn FC, Vandenbogaerde JF, Vogelaers DP, et al. Use of dopexamine hydrochloride in patients with septic shock. Crit Care Med 1989;17:999-1003.
Smithies M, Yee TH, Jackson L, et al. Protecting the gut and the liver in the critically ill: Effects of dopexamine. Crit Care Med 1994;22:789-795.
Vincent JL, Reuse C, Kahn RJ. Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure. Chest 1989;96:1233-1236.
Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
Evans T, Carpenter A, Kinderman H, et al. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993;41:77-81.
Krafte-Jacobs B, Brilli R, Szabo C, et al. Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 1997;25:1588-1593.
Hollenberg SM, Cunnion RE, Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 1993;264:H660-H663.
Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels inpatients after trauma and during sepsis. Ann Surg 1991;214:621-626.
Forstermann U, Schimidt HW, Pollock JS. Isoforms of nitric oxide synthase: Characterization and purification from different cell type. Biochem Pharmacol 1991;42:1849-1856.
Gray G, Schott C, Julou-Schaeffer G, et al. The effects of inhibitors of the L-arginine/nitric oxide pathway on endotoxininduced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 1991;103:1218-1244.
Nava E, Palmer RMJ, Moncada S. The role of nitric oxide in endotoxic shock: Effects of NG monomethyl-L-arginine. J Cardiovasc Pharmacol 1992;20:S132-S134.
Freeman BD, Zeni F, Banks SM, et al. Response of the septic vasculature to prolonged vasopressor therapy with Nomegamonomethyl- L-arginine and epinephrine in canines. Crit Care Med 1998;26:877-886.
Robertson FM, Offner PJ, Ciceri DP, et al. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994;129:149-156.
Petros A, Lamb G, Leone A, et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1995;28:34-39.
Lorente JA, Landin L, De Pablo R, et al. L-arginine pathway in the sepsis syndrome. Crit Care Med 1993;21:1287-1295.
Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
Harbrecht BG, Billiar TR, Stadler J, et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992;52:390-394.
Cobb JP, Natanson C, Hoffman WD, et al. Nomega-amino-Larginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992;176:1175-1182.
Statman R, Cheng W, Cunningham JN, et al. Nitric oxide inhibition in the treatment on the septic syndrome is detrimental to tissue oxygenation. J Surg Res 1994;57:93-98.
Grover R, Lopez A, Lorente J, et al. Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: Effects on survival in patients with septic shock. Abstr Crit Care Med 1999;27:27-A33.
Aranow JS, Zhuang J, Wang H, et al. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies. Shock 1996;5:116-121.
Rouselet A, Feihl F, Markert M, et al. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med 1998;158:162-170.
Preiser JC, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: A clinical trial. Crit Care Med 1995;23:259-264.
Stein B, Pfenninger E, Grunert A, et al. Influence of continuos haemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990;16:494-499.
Grotendorst AF, van Bommel EF, van der Hoven B, et al. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-240.
Griffin MP, Zwischenberger JB, Minifee PK, et al. Extracorporeal membrane oxygenation for Gramnegative septic shock in the immature pig. Circ Shock 1991;33:195-199.
Bottoms G, Fessler J, Murphey E, et al. Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. Shock 1996;5:149-154.
Beca J, Butt W. Extracorporeal membrane oxygenation for refractory septic shock in children. Pediatrics 1994;93:726-729.
McCune S, Short BL, Miller MK, et al. Extracorporeal membrane oxygenation therapy in neonates with septic shock. J Pediatr Surg 1990;25:479-482.
Goldman AP, Kerr SJ, Butt W, et al. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997;349:466-469.
Bellomo R, Tipping P, Boyce N. Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. ASAIO Trans 1991;37:M322-M323.
Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis remove cytokines the circulation of septic patients. Crit Care Med 1993;21:522-526.
Hoffmann JN, Hartl WH, Deppisch R, et al. Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 1995;48:1563-1570.
Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Mutuschak GM, et al. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med 1999;27:1230-1251.
Crouser ED, Julian MS, Blaho DV, Pfeiffer DR. Endotoxin mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002;30:276-284.
Alonso de Vega JM, Díaz J, Serrano E, Carbonell L. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002;30:1782-1786.
Asafar P, Nalos M, Pittner A, Theisen M, Ichai C, Ploner F, et al. Adenosine triphosphate-magnesium dichloride during hyperdynamic porcine endotoxemia: Effects on hepatosplanchnic oxygen exchange and metabolism. Crit Care Med 2002;30:1826-1833.
Anguera I, Pare C, Perez-Villa F. Severe right ventricular dysfunction following pericardiocentesis for cardiac tamponade [letter]. Int J Cardiol 59:212-214.
Armstrong WF, Feigenbaum H, Dillon JC. Acute right ventricular dilation and echocardiographic volume overload following pericardiocentesis for relief of cardiac tamponade. Am Heart J 1984;107:1266-1270. 212a. Poeze M, Ramsay G, Jan Willem G, Mervyn S. Prediction of postoperative cardiac surgical morbidity and organ failure within 4 hours of intensive care unit admission using esophageal Doppler ultrasonography. Crit Care Med 1999;27:1288-94.
Celermajer DS, Boyer MJ, Bailer BP, et al. Pericardiocentesis for symptomatic malignant pericardial effusion: A study of 36 patients. Med J Aust 1991;154:19-22.
Goldberg RJ, Gore JM, Alpert JS. Cardiogenic Shock after Acute Myocardial Infarction. Incidence and mortality from a community- wideperspective, 1975 to 1988. N Engl J Med 1991;325:1117-1122.
Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-1168.
Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic Shock: The GUSTO-I trial experience : The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995;26:668-674.
Hochman JS, Boland J, Sleeper LA, brinker J, Col J, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: Results of International Registry. SHOCK Registry Investigators. Circulation 1995;91:873-881.
Califf RM, Bengston JR. Cardiogenic Shock. N Engl J Med 1994;330:1724-1730.
Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989;14:40-46.
Hasdai D, Califf RM, Thompson TD, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000;35:136-143.
Zehender M, Kasper W, Kauder E, Schonthaler, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993;328:981-8.
Jacobs AK, Leopold JA, et al. Cardiogenic Shock caused by Right ventricular Infarction. J Am Coll Cardiol 2003;41:1273-9.
Dell’Italia LJ, Starling MR, Blumhardt et al. Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation 1985;72:1327-35.
Kinch JW, Ryan TJ. Right ventricular infarction. N Engl J Med 1994;330:1211-7.
Bowers TR, O’Neill WW, Grines C, et al. Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998;338:933-40.
Moore KE, Murtaugh RJ. Pathophysiologic characteristics of hypovolemic shock. Vet Clin North Am Small Anim Pract 2001;31(6):1115-28.
Cheung AT, Jahr JS, Driessen B, Duong PL, Chan MS, Luri EF. The effects of hemoglobin glutamer-200 (bovine) on the microcirculation in a canine hypovolemia model: a noninvasive computer-assisted intravital microscopy study. Anesth Analg 2001;93(4):832-8.
Ba ZF, Wang P, Koo DJ, Ornan DA, Bland KI, Chaudry IH. Attenuation of vascular endothelial dysfunction by testosterone receptor blockade after trauma and hemorrhagic shock. Arch Surg 2001;136(10):1158-63.
Pannen BH, Schroll S, Loop T, Bauer M, Hoetzel A, Geiger KK. Hemorrhagic shock primes the hepatic portal circulation for the vasoconstrictive effects of endothelin-1. Am J Physiol 2001;281(3):1075-84.
Pulmonary Artery Catheter Consensus Conference Participants. Pulmonary Artery Catheter Consensus Conference: Consensus statement. Crit Care Med 1997;25:910-24.
Heyland DK, Cook DJ, King D, et al. Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Crit Care Med 1996;24:517-24.
Aronis M, Corvo P, Barone JE, et al. Preoperative pulmonary artery catheterization has no impact on outcome. Contemp Surg 1998;53:25-9.
Cucherat M, Boissel J-P, Leizorovicz A, Haugh MC, Easy MA. A program for the meta-analysis of clinical trials. Comput Methods Progr Biomed 1997;53:187-90.
Berlauk JF, Abrams JH, Gilmour IJ, et al. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. Ann Surg 1991;214:290-9.
Berlauk JF. Reply to letter. Ann Surg 1992;216:103.
Bender JS, Smith-Meek MA, Jones CE. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery. Ann Surg 1997;226:229-37.
Ziegler DW, Wright JG, Choban PS, Flancbaum L. A prospective randomized trial of preoperative “optimization” of cardiac function in patients undergoing elective peripheral vascular surgery. Surgery 1997;22:584-92.
Isaacson IJ, Lowdon JD, Berry AJ, et al. The value of pulmonary artery and central venous monitoring in patients undergoing abdominal aortic reconstructive surgery: A comparative study of two selected, randomized groups. J Vasc Surg 1990;12:754-60.
Joyce WP, Provan JL, Ameli FM, et al. The role of central haemodynamic monitoring in abdominal aortic surgery: A prospective randomized study. Eur J Vasc Surg 1990;4:633-636.
Valentine R J, Duke ML, Inman MH, et al. Effectiveness of pulmonary artery catheters in aortic surgery: A randomized trial. J Vasc Surg 1998;27:203-12.
Swan HJ, Ganz W, Forrester J, et al. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970;283:447-51.
Robin ED, The cult of the Swan-Ganz catheter: Overuse and abuse of pulmonary flow catheter. Ann Intern Med 1985;103:445-9.
Conners Af, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996;276:889-97.
Iberti TJ, Fischer EP, Leibawitz AB, et al. A multicenter study of physicians knowledge of the pulmonary artery catheter. JAMA 1990;264:2928-32.
Trunkey D. Discussion of Bender et al. Ann Surg 1997;226:236.
Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs colloids in fluid resuscitation: A systematic review. Crit Care Med 1999;27:200-10.
Detsky AS, Naylor CD, O’Rourke K, et al. Incorporating variations in the quality of individual randomized trials into metaanalysis. J Clin Epidemiol 1992;45:255-65.
Sacks HS, Berrier J, Reitman D, et al. Meta-analysis of randomized controlled trials. N Engl J Med 1987;316:450-5.
Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in highrisk patients undergoing vascular surgery. N Engl J Med 1999;341:1789-94.
Adams JG, Clifford E J, Henry RS, Poulos E. Selective monitoring in abdominal aortic surgery. Am Surg 1993;59:559-63.
Lugo G, Arispe D, Dominguez G, Ramirez M, Tamariz-Cruz O. DO2 / VO2 Relationship During Anesthesia In High Risk Surgical Patients. Crit Care Med 1993;21:64-69.
Boyds O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993;270:2699-707.
Flancbaum L, Ziegler DW, Choban PS. Preoperative intensive care unit admission and hemodynamic monitoring in patients scheduled for major elective noncardiac surgery: A retrospective review of 95 patients. J Cardiothorac Vasc Anesth 1998;12:3-9.
Grant KC. Utility and application of pulmonary artery catheterization in aortic and aorto-iliac disease. Can J Surg 1986;29:256-8.
Hesdorffer CS, Milne JF, Meyers AM, et al. The value of Swan-Ganz catheterization and volume loading in preventing renal failure in patients undergoing abdominal aneurysmectomy. Clin Nephrol 1987;28:272-6.
Mostafa G, Kumar M, Schlotthauer J, Murray MJ. The utility of hemodynamic measurements acquired by pulmonary artery catheterization. Am J Surg 1998;175:293-6.
Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in highrisk surgical patients. Chest 1998;94:1176-86.
Shoemaker WC, Appel PL, Kram HB. Hemodynamic and oxygen transport responses in survivors and non-survivors in highrisk surgery. Crit Care Med 1993;21:997-9.
Tuman KJ, McCarthy R J, Spiess BD, et al. Effective pulmonary artery catheterization on outcome and patients undergoing coronary artery surgery. Anesthesiology 1989;70:199-206.
Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: Randomized controlled trial of preoperative optimization of oxygen delivery. BMJ 1999;318:1099-1103.
Yang SC, Pud VK. Role of preoperative hemodynamic monitoring in intraoperative fluid management. Ann Surg 1986;52:536-40.
Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002;30:1686-1692.
Romano SM, Pistolesi M. Assessment of cardiac output from systemic arterial pressure in humans. Crit Care Med 2002;30:1834-1841.
Barone JE, Corvo PR, Tucker JB, Rassias D. Routine Perioperative Pulmonary Artery Catheterization has no Effect on rate of Complications in Vascular Surgery: A Meta-Analysis. American Surgeon 2001;67:674-80.
McCallum AL, Rubes C. Prehospital Interventions. Emerg Med Clin North Am 1996;14:1-12.
Cadigan R, Bugarini D. Predicting demand for emergency ambulance service. Ann Emerg Med 1989;18:618-621.
Boyle JJ, Hatton D, Sheets C. Surgical cricothyroidotomy performed by air ambulance flight nurses: A five year experience. J Emerg Med 1993;11:41-45.
Holroyd BR, Knopp R, Kallsen G. Medical Control: Quality Assurance in prehospital care. JAMA 1986;256:1027-1031.
Kellerman Al, Hackman BB, Somes G. Prediction the outcome of unsuccessful prehospital Advanced Cardiac Life Support. JAMA 1993;270:1433-3.
Texto completo
Cómo citar este artículo
Artículos similares